Question? Call us
212-363-750060
Days Left
Lead Plaintiff Deadline
Dec 28, 2026
Please Upload related files below
Fill in below.
Tell us the stocks you own using SnapTrade, and we will keep you informed about class action litigation related to your stocks. We monitor critical case developments that may affect the price of your shares and your possible monetary recovery. SnapTrade only shares the tickers you own and your transaction history, not your account numbers. Using SnapTrade and participating in our monitoring service is free and does not create any attorney-client relationship or obligation on your part.
Don’t miss out on possible monetary recovery - link your brokerage account with SnapTrade.
According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material facts concerning the true state of O-I Glass’ Fit to Win program, including the delay in achieving its targeted cost savings, higher than expected expenses, operational disruptions that materially offset Fit to Win benefits, and continued competitive and energy-cost pressures affecting its European operations. On July 28, 2026, O-I Glass announced its second quarter 2026 financial results, substantially reducing its 2026 adjusted EBITDA and free cash flow guidance and realigning its 2027 Investor Day financial targets. On this news, the price of O-I Glass’ common stock declined from a closing market price of $9.06 per share on July 28, 2026, O-I Glass’ stock price fell to $7.70 per share on July 29, 2026, a decline of about 15%.
Investors who purchased or otherwise acquired O-I Glass securities within the class period described above and suffered losses may be eligible.
If you suffered a loss in O-I Glass during the relevant time frame or pursuant to the relevant offering(s), you have until December 28, 2026 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
● The Allegation: The complaint alleges that O-I Glass made materially false and misleading statements by repeatedly touting the success of its Fit to Win cost-savings program and reaffirming its 2026 outlook and $1.45 billion 2027 Investor Day targets, while allegedly concealing delays in achieving targeted cost savings, higher than expected expenses, operational disruptions, and persistent competitive and energy-cost pressures in its European operations.
● The Stock Drop: On July 29, 2026, OI stock fell from a closing price of $9.06 per share on July 28, 2026, to $7.70 per share, a decline of about 15%, after the company announced disappointing second quarter 2026 results, reduced its 2026 guidance, and realigned its 2027 Investor Day targets.
● Class Period & Defendants: The class period runs from March 14, 2025, through July 28, 2026, inclusive. The named defendants are O-I Glass, Inc., Gordon J. Hardie (President, Chief Executive Officer and Director), and John A. Haudrich (Senior Vice President and Chief Financial Officer).
● Lead Plaintiff Deadline: December 28, 2026. Investors who wish to seek appointment as lead plaintiff must apply by the deadline.
|
O-I Glass Class Action Summary |
|
|
Company |
O-I Glass, Inc. (NYSE: OI) |
|
Lead Plaintiff Deadline |
December 28, 2026 |
|
Class Period |
March 14, 2025 – July 28, 2026 |
|
Stock Drop |
July 29, 2026 – OI fell $1.36 (about 15%) to $7.70 |
A securities class action lawsuit has been filed against O-I Glass, Inc. (NYSE: OI). The plaintiff brought the case on behalf of investors who purchased or otherwise acquired O-I Glass common stock during the class period, from March 14, 2025, through July 28, 2026.
The complaint alleges that O-I Glass made materially false and misleading statements about its Fit to Win cost-savings program and its 2026 financial outlook. The company said it was on track to meet its 2027 targets. But the lawsuit claims it hid delays in cost savings, rising expenses, and ongoing trouble in its European operations.
After the market closed on July 28, 2026, O-I Glass announced disappointing second-quarter financial results, cut its 2026 guidance, and realigned its 2027 targets. The stock then fell about 15% the next day. The complaint alleges investors suffered losses following the disclosure.
O-I Glass, Inc. is a global manufacturer of glass containers for food, beverages, and pharmaceuticals. Its products include glass containers for beer, spirits, wine, food, soft drinks, teas, juices, and pharmaceuticals, serving customers in the United States, Europe, and other international markets. The company is headquartered in Perrysburg, Ohio, and its common stock trades on the New York Stock Exchange under the symbol OI.
March 14, 2025–July 28, 2026
Investors who purchased or otherwise acquired O-I Glass (OI) common stock during the Class Period may be eligible to seek recovery under the federal securities laws.
The complaint centers on O-I Glass's Fit to Win initiative, a program the company presented as a core value driver intended to reduce costs, improve competitiveness, and support its financial targets. According to the complaint, defendants Gordon J. Hardie and John A. Haudrich repeatedly provided investors with positive statements about the program's progress and the company's expected financial outlook for 2026, including expectations for adjusted EBITDA and free cash flow, as well as growth expectations for its glass-packaging business.
Beginning at the company's March 14, 2025 Investor Day, the complaint alleges that defendants reaffirmed a 2027 commitment of $1.45 billion in EBITDA, free cash flow of 5% of revenue, and introduced preliminary 2029 objectives. Through subsequent quarterly results and investor conferences, defendants emphasized Fit to Win benefits that allegedly exceeded management expectations, raised full-year 2025 guidance multiple times, and increased the cumulative Fit to Win savings target to at least $750 million. The lawsuit claims defendants consistently characterized headwinds in the European operations, including competitive pricing pressure and energy costs, as temporary and front-loaded.
The complaint alleges these statements were materially false and misleading because, in truth, the company was experiencing higher than expected expenses associated with plant closures and restructuring, operational disruptions that materially offset Fit to Win benefits, and continued energy-cost pressures affecting its European operations. According to the complaint, these conditions made the $1.45 billion 2027 Investor Day financial target increasingly unlikely to be met.
The lawsuit claims defendants knew, should have known, or recklessly disregarded that the company's public statements were false and misleading when made. The complaint alleges defendants had actual knowledge of, or access to, non-public information concerning the timing and effectiveness of the Fit to Win program in Europe and the amount of expected cost savings, yet continued to minimize the European weakness while reaffirming guidance and touting the program's success.
After the market closed on July 28, 2026, O-I Glass announced second quarter 2026 financial results that fell materially below expectations. The company revised its 2026 guidance and realigned its 2027 targets to reflect current business headwinds and a more gradual rate of improvement. The results included a reported loss of $6.33 per share, which incorporated an $873 million non-cash goodwill impairment charge and a $96 million increase to deferred tax valuation allowances, both related to Europe. Europe segment operating profit was just $6 million, compared to $90 million in the prior year, reflecting competitive pricing pressure, elevated energy costs, and temporary operational disruption following major restructuring actions.
According to the complaint, these disclosures stood in direct contrast to defendants' prior statements that had continually praised the progress of the Fit to Win program, touted its substantial cost-saving benefits, and reaffirmed the 2026 outlook and 2027 Investor Day targets. The lawsuit claims defendants had minimized risks posed by cost-saving delays, higher than expected expenses, operational disruptions, and continued commercial and energy-cost pressures affecting the European operations. Defendant Hardie acknowledged on the earnings call that the company had experienced a "stumble, a chunk of it of our own making," attributing the shortfall to commercial pressures, higher energy-related costs, and operational challenges in Europe.
Analysts reacted sharply to the news. Truist Securities lowered its price target to $10.00 from $13.00, citing weak European demand and "poor execution stemming from three plant rationalizations in France." UBS lowered its price target by 26%, noting management's explanation about operating disruptions was "disappointing." Baird Equity Research cut its price target to $13.00 from $15.00, pointing to operational inefficiencies in the context of the restructuring program and a sharp decline in projected earnings.
Investors and analysts reacted immediately to the disclosures. O-I Glass common stock declined from a closing price of $9.06 per share on July 28, 2026, to $7.70 per share on July 29, 2026, a decline of approximately 15%. According to the complaint, the second quarter 2026 results reflected an approximately 25% year-over-year decline in adjusted EBITDA and a substantial shortfall in the European operations, and the company's revision of its 2026 outlook and realignment of its 2027 Investor Day targets drove the drop in the stock price.
● Lead Plaintiff Deadline: December 28, 2026
● After the lead plaintiff deadline, the Court will consider any lead plaintiff motions.
● Defendants may file a motion to dismiss.
● If the case proceeds, the Court may later consider class certification.
Disclaimer: This shareholder alert is for informational purposes only and does not constitute legal advice. Consult a qualified attorney for personalized guidance. Prior results do not guarantee similar outcomes.
The lawsuit is a federal securities class action filed on behalf of investors who purchased O-I Glass, Inc. (NYSE: OI) common stock between March 14, 2025, and July 28, 2026. The complaint alleges that O-I Glass and two of its executives made materially false and misleading statements about the company's Fit to Win cost-savings program and its 2026 financial outlook, while allegedly concealing cost-savings delays, higher expenses, operational disruptions, and persistent competitive and energy-cost pressures in its European operations that made its 2027 targets increasingly unlikely to be met.
The defendants are O-I Glass, Inc. and two individual defendants: Gordon J. Hardie, who served as President, Chief Executive Officer, and Director, and John A. Haudrich, who served as Senior Vice President and Chief Financial Officer. According to the complaint, both individual defendants had the power and authority to control the contents of O-I Glass's SEC reports, press releases, and presentations to analysts and investors, and the lawsuit alleges they are liable for the statements described in the complaint.
The class period runs from March 14, 2025, through July 28, 2026, inclusive. Investors who purchased or acquired O-I Glass common stock during this period may be eligible to seek recovery under the federal securities laws. The complaint alleges the class period began with the company's March 14, 2025 Investor Day, where defendants reaffirmed their 2027 financial targets, and ended when the company disclosed disappointing results and revised guidance after the market closed on July 28, 2026.
According to the complaint, O-I Glass common stock declined from a closing price of $9.06 per share on July 28, 2026, to $7.70 per share on July 29, 2026, a decline of approximately 15%. The drop followed the company's announcement of second quarter 2026 results that fell materially below expectations, including an approximately 25% year-over-year decline in adjusted EBITDA, a substantial shortfall in the European operations, and a revision of its 2026 guidance and 2027 Investor Day targets.
Fit to Win was O-I Glass's cost-savings and restructuring initiative, which the company described as a core value driver intended to reduce costs, improve competitiveness, and support its financial targets. According to the complaint, defendants repeatedly touted the program's benefits, raised its cumulative savings target to at least $750 million, and used it to reaffirm confidence in achieving the company's 2027 Investor Day targets. The lawsuit alleges defendants concealed that operational disruptions and other expenses were materially offsetting the program's benefits, particularly in Europe.
The lead plaintiff deadline is December 28, 2026.
Investors who purchased or acquired O-I Glass, Inc. (NYSE: OI) common stock during the class period, from March 14, 2025, through July 28, 2026, may be eligible to seek recovery under the federal securities laws. Eligibility generally depends on when you purchased or otherwise acquired your shares and whether you suffered financial losses following the alleged corrective disclosure identified in the complaint. The complaint seeks to represent all investors who purchased O-I Glass common stock during the class period and were damaged upon the revelation of the alleged corrective disclosure.
The securities class action alleges O-I Glass (NYSE: OI) made materially false and misleading statements about its Fit to Win cost-savings program and 2026 outlook, while allegedly concealing cost-savings delays, higher expenses, and ongoing trouble in its European operations.
The class period runs from March 14, 2025, through July 28, 2026, inclusive. Investors who purchased O-I Glass common stock during this period may be eligible to seek recovery under the federal securities laws.
O-I Glass stock fell from $9.06 per share on July 28, 2026, to $7.70 per share on July 29, 2026, a decline of about 15%, after the company cut its 2026 guidance and realigned its 2027 targets.
The defendants are O-I Glass, Inc., Chief Executive Officer Gordon J. Hardie, and Chief Financial Officer John A. Haudrich.
The lead plaintiff deadline is December 28, 2026.
Deadline
Dec 28, 2026